Drug Type Protein drugs |
Synonyms |
Target |
Mechanism IL1R1 antagonists(Interleukin-1 receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Onspira Therapeutics, Inc.Startup |
Active Organization Altavant Sciences, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Bronchiolitis Obliterans | Preclinical | US | Altavant Sciences, Inc.Startup | - |
Bronchiolitis | Discovery | US | Altavant Sciences, Inc.Startup | 18 Feb 2021 |